Computational Drug Repurposing of H1-Antihistamines for Inhibiting Tumour Progression in Pancreatic Cancer: An In Silico Evaluation
Background: Pancreatic adenocarcinoma (PAAD) is one of the most aggressive malignancies, characterized by poor prognosis, early metastasis, and limited therapeutic options. Drug repurposing has emerged as an attractive strategy for identifying novel anticancer agents by utilizing the established safety profiles of appr...